MENU
+Compare
ADTX
Stock ticker: NASDAQ
AS OF
Dec 23, 12:42 PM (EDT)
Price
$0.21
Change
+$0.02 (+10.53%)
Capitalization
2.7M

ADTX Aditxt Inc Forecast, Technical & Fundamental Analysis

a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies

Industry Biotechnology
ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ADTX with price predictions
Dec 20, 2024

Momentum Indicator for ADTX turns negative, indicating new downward trend

ADTX saw its Momentum Indicator move below the 0 level on December 12, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADTX entered a downward trend on November 27, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADTX advanced for three days, in of 172 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.562) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). ADTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.048) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADTX is expected to report earnings to rise 4,058.27% to -11559 cents per share on August 30

Aditxt Inc ADTX Stock Earnings Reports
Q2'23
Est.
$-115.60
Q1'23
Est.
$-2.78
Q4'22
Missed
by $0.48
Q3'22
Missed
by $1.38
Q2'22
Missed
by $253.50
The last earnings report on May 31 showed earnings per share of -277 cents, meeting the estimate of -277 cents. With 2.18M shares outstanding, the current market capitalization sits at 2.70M.
A.I. Advisor
published General Information

General Information

a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHOT0.720.04
+6.58%
Safety Shot
SNOA2.630.08
+3.14%
Sonoma Pharmaceuticals Inc
COHR97.671.49
+1.55%
Coherent Corp
EBF20.68-0.35
-1.66%
Ennis
CNK30.83-0.54
-1.72%
Cinemark Holdings

ADTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADTX
1D Price
Change %
ADTX100%
-17.65%
ORMP - ADTX
32%
Poorly correlated
-4.82%
CSCI - ADTX
28%
Poorly correlated
-10.55%
XTLB - ADTX
27%
Poorly correlated
-1.03%
BDRX - ADTX
25%
Poorly correlated
-0.25%
APRE - ADTX
25%
Poorly correlated
-5.57%
More